NEW YORK--(BUSINESS WIRE)--Neuro-Hitech, Inc. (NASDAQ: NHPI - News), a New York-based biopharmaceutical company focused on developing innovative drugs for the treatment of neurodegenerative diseases, announced today that it had received notice on March 24, 2008 from the NASDAQ Stock Market (“NASDAQ”) that the Company had not regained compliance with Marketplace Rule 4310(c)(3)(B), which requires the Company’s market value of its listed securities to remain at or above the $35,000,000 minimum. The Company had received a warning letter from NASDAQ on February 19, 2008 which granted the Company, in accordance with Marketplace Rule 4310(c)(8)(C), 30 calendar days, or until March 20, 2008, to regain compliance.
